© 2021 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
December 12, 2016
Pharmacokinetics of CT-P10 were highly similar to originator products.
December 10, 2016
Supreme Court will rule on the validity of the timing.
December 09, 2016
Physicians will make their own decisions as to which patients might benefit most from biosimilars therapy.
Sandoz received a complete response letter from the US Food and Drug Administration (FDA) in regard to its pegfilgrastim biosimilar application, filed in 2015.